High-dose-rate stereotactic brachytherapy for patients with newly diagnosed glioblastoma multiformes

Journal of Neuro-Oncology

Volumn 61, Issue 1, 2003, Pages 45-55

  Chang, Chen Nen ^a   Chen, Wen Cheng ^a   Wei, Kuo Chen ^a   Ng, Shu Hang ^a   Ho, Yat Sen ^a   Huang, David Ying Chung Huang ^b   Lee, Steve Pai Hsun ^c   Hong, Ji Hong ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Sun Yat Sen Cancer Center   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Glioblastoma multiforme; High dose rate; Radiation therapy; Stereotactic brachytherapy

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; IRIDIUM 192; PROCARBAZINE; VINCRISTINE;

ADULT; AGE; AGED; ANALYTICAL PARAMETERS; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; BRAIN INJURY; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MINIMAL RESIDUAL DISEASE; MULTIVARIATE ANALYSIS; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SEIZURE; STATISTICAL SIGNIFICANCE; STEREOTAXIC SURGERY; SURVIVAL RATE; SURVIVAL TIME; WOUND INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RADIOSURGERY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0037270070     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021270201988     Document Type: Article

References (28)

1. Chang CH, Hornton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y: Comparison of postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52 (6): 997-1007, 1983
2. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adult. Cancer 71 (8): 2585-2597, 1993
3. Hochberg FH, Pruitt A: Assumption in the radiotherapy of glioblastoma. Neurology 67: 907-911, 1980
4. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16(6): 1405-1409, 1989
5. Walker MD, Strike TA, Sheline GE: An analysis of dose effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5(10): 1725-1731, 1979
6. Gutin PH, Leibel SA, Wara WM, Choucair A, Levin VA, Philips TL, Silver P, Da Silva V, Edwards MS, Davis RL: Recurrent malignant gliomas: Survival following interstitial brachytherapy with high activity iodine-125 sources. J Neurosurg 67(6): 864-873, 1987
7. Gutin PH, Prados MD, Phillips TL, Wara WM, Larson DA, Leibel SA, Sneed PK, Levin VA, Weaver KA, Silver P, Lamborn K, Lamb S, Ham B: External irradiation followed by an interstitial high activity iodine-125 implant 'boost' in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 21 (3): 601-606, 1991
8. Loeffler JS, Alexander E III, Wen PY, Shea WM, Coleman CN, Kooy HM, Fine HA, Nedzi LA, Silver B, Riese NE, Black PM: Results of stereotactic brachytherapy used in the initial treatment of malignant glioblastoma. J Natl Cancer Inst 82(24): 1918-1921, 1990
9. Prados MD, Gutin PH, Phillips TL, Wara WM, Sneed PK, Larson DA, Lamb SA, Ham B, Malec MK, Wilson CB: Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: The UCSF experience. Int J Radiat Oncol Biol Phys 24(4): 593-597, 1992
10. Wen PY, Alexander E, III, Black PM, Fine HA, Riese N, Levin JM, Coleman CN, Loeffler JS: Long term results of stereotactic brachytherapy used in the initial treatment of malignant gliomblastoma. Cancer 73(12): 3029-3036, 1994
11. Garcia DM, Zamorano L, Mundinger F: High-dose rate brachytherapy in the treatment of malignant gliomas. In: Nag S (eds) High Dose Rate Brachytherapy: A Textbook. Futura Publishing Company, New York, 1991, pp 215-235
12. Johannesen TB, Watne K, Lote K, Norum J, Hennig R, Tvera K, Hirschberg: Intracavitary fractionated balloon brachytherapy in glioblastoma. Acta Neurochir 141: 127-133, 1999
13. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE, Nelson DF: Recursive partitioning analysis in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85(9): 704-710, 1993
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481, 1958
15. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966
16. Cox DR: Regression models and life-tables. J R Stat Soc 34: 187-220, 1972
17. Bernstein M, Laperriere N, Leung P, McKenzie S: Interstitial brachytherapy for malignant brain tumor: Preliminary results. Neurosurgery 26(3): 371-379, 1990
18. Videtic GMM, Gaspar LE, Zamorano L, Fontanesi J, Levin KJ, Kupsky WJ, Tekyi-Mensah S: Use of the RTOG partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas. Int J Radiat Oncol Biol Phys 45(3): 687-692, 1999
19. Gaspar LE, Qian C, Kocha WI, Coia LR, Herskovic A, Graham M: A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): Preliminary toxicity report. Int J Radiat Oncol Biol Phys 37(3): 593-599, 1997
20. Gollins SW, Burt PA, Barber PV, Stout R: High dose rate intraluminal radiotherapy for carcinoma of the bronchus: Outcome of treatment of 406 patients. Radiother Oncol 33(1): 31-40, 1994
21. Martinez A, Gonzalez J, Stromberg J, Edmundson G, Plunkett M, Gustafson G, Brown D, Yan D, Vicini F, Brabbins D: Conformal prostate brachytherapy: Initial experience of a phase I/II dose-escalating trial. Int J Radiat Oncol Biol Phys 33(5): 1019-1027, 1995
22. Mate TP, Gottesman JE, Hatton J, Gribble M, Hollebeke LV: High dose-rate afterloading Iridium-192 prostate brachytherapy: Feasibility report. Int J Radiat Oncol Biol Phys 41(3): 525-533, 1998
23. Sarkaria JN, Petereit DG, Stitt JA, Hartman T, Chappell R, Thomadsen BR, Buchler DA, Fowler JF, Kinsella TJ: A comparison of the efficacy and complication rates of low-dose-rate versus high-dose-rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 30(1): 75-82, 1994
24. Wang CJ, Leung SW, Chen HC, Sun LM, Fang FM, Changchien CC, Huang EY, Wu JM, Chen CC: High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme. Int J Radiat Oncol Biol Phys 38(2): 391-398, 1997
25. Sneed PK, Stauffeer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH: Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40(2): 287-295, 1998
26. Laperriere NJ, Leung PMK, McKenzie S, Miloevic M, Wong S, Glen J, Pintilie M, Bernstein M: Randomized study of brachytherapy in the initial management of patients with malignant astrocytoma. Int J Radiat Oncol Biol Phys 41(5): 1005-1011, 1998
27. Florell RC, MacDonald DR, Irish WD, Bernstein M, Leibel SA, Gutin PH, Cairncross JG: Selection bias, survival, and brachytherapy for glioma. J Neurosurg 76(2): 179-183, 1992
28. Koot RW, Maaroufu, Hulshof MC, Voges J, Treuer H, Koedooder C, Sturm V, Bosch DA: Brchytherapy: Results of two different therapy strategies for patients with primary glioblastoma multiforme. Cancer 88(12): 2796-2802, 2000